What is Vulvar Embryonal Rhabdomyosarcoma?
Vulvar embryonal rhabdomyosarcoma is a rare type of cancer that can affect both boys and girls in early childhood. It often presents as a vaginal mass in girls under the age of eight, leading to vaginal bleeding. In addition to vulvar rhabdomyosarcoma, other forms of rhabdomyosarcoma can develop in the head and neck, extremities (arms, legs), genitalia, and urinary system.
Causes
Rhabdomyosarcoma is linked to inherited genetic conditions such as neurofibromatosis 1, Noonan syndrome, Li-Fraumeni syndrome, Beckwith-Wiedemann syndrome, and Costello syndrome.
Signs and Symptoms
Patients may experience the following symptoms:
- Vaginal bleeding
- A protruding mass from the vagina resembling a bunch of grapes
- The tumour may metastasise (spread) to nearby lymph nodes, deeper pelvic tissues, and distant organs such as bones and muscles. This can lead to additional symptoms like extreme weight loss, fragile bones that fracture easily, and generalised body pain.
Diagnosis
The following tests and procedures are helpful for diagnosis:
- Karyotyping: To check for chromosomal abnormalities and rule out testicular remnants in vulvar tissue.
- Ultrasound: Used to differentiate between a lump inside the labia and a hernia, and to identify benign growths like vulvar hematomas.
Treatment
In the early stages of vulvar embryonal rhabdomyosarcoma, the primary treatment is surgical removal of the affected parts of the vulva, vagina, and labia. In advanced or metastatic cases, a combination of surgery, chemotherapy, and radiation therapy is used to treat the disease.
In addition to surgery, chemotherapy, and radiation therapy, there are other treatments that can be considered for vulvar embryonal rhabdomyosarcoma, particularly in advanced or recurrent cases. These include:
-
Targeted Therapy
Targeted therapy involves drugs designed to attack specific molecules within cancer cells, such as proteins or genes that are driving the tumour’s growth. For rhabdomyosarcoma, some targeted therapies are being explored to disrupt key pathways involved in tumour growth and survival.
-
Immunotherapy
Immunotherapy aims to boost the body’s immune system to fight cancer. This approach is still under investigation for rhabdomyosarcoma but has shown promise in certain cancers. It includes treatments like immune checkpoint inhibitors, which help the immune system recognise and attack cancer cells more effectively.
-
Clinical Trials
Clinical trials offer access to experimental treatments that are not yet widely available. These might include new chemotherapy drugs, targeted therapies, or combinations of different treatment approaches.
-
Hormone Therapy
In some types of rhabdomyosarcoma, particularly if the tumour cells express hormone receptors, hormone therapy might be considered to block hormones that could promote cancer growth.
-
Stem Cell Transplantation
In cases of aggressive or recurrent rhabdomyosarcoma, high-dose chemotherapy followed by a stem cell transplant may be considered. This involves the use of the patient’s or a donor’s stem cells to help recover after intensive chemotherapy.
-
Palliative Care
For cases where a cure is not possible, palliative care can help manage symptoms and improve the quality of life. This includes pain management, nutritional support, and treatments to manage other symptoms caused by the tumour or its metastasis.
These treatments are usually part of a multidisciplinary approach and tailored to each patient based on the stage of the disease, location of the tumour, and overall health. Participation in clinical trials or discussions with an oncologist about new and emerging therapies may also provide additional options.
You can help us with your donation:
Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:
